MagicRNA
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 18
About MagicRNA
, trading as MagicRNA, operates as a biotechnology company dedicated to developing RNA drugs. It has applied for more than ten invention patents, including multiple PCT and European and American invention patents, of which 4 patents have been authorized. The company cooperated with Sun Yat-sen University Affiliated Hospital, West China Hospital, and other hospitals in the fields of urology, gynecological oncology, and other fields. The company engages in the R&D of mRNA drugs for gynecological diseases and urinary system tumors, based on the self-development of three technology platforms, including the mRNA sequence design platform, the mRNA synthesis platform, and the lipid nanoparticles (LNP) delivery platform. The company has product lines such as infectious disease mRNA vaccines, mRNA tumor vaccines, and protein replacement therapies. Magic RNA developed Engineered Cell Targeted LNPs (EnC-LNPs) platform, which provides solutions for extrahepatic delivery of nucleic acid drugs. The company's first tumor therapeutic drug, HN2201, has completed preclinical development. The company's revenue is generated by providing mRNA and circular RNA products, custom mRNA synthesis, and LNP encapsulation services to biotech and pharmaceutical clients.
Who invested in MagicRNA
18 investors across 3 rounds
See all investors in MagicRNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MagicRNA
Who invested in MagicRNA?
MagicRNA has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MagicRNA raised?
MagicRNA has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did MagicRNA last raise money?
MagicRNA's most recent round on record is a Series B, in Aug 2026.
What does MagicRNA do?
, trading as MagicRNA, operates as a biotechnology company dedicated to developing RNA drugs.
Where is MagicRNA headquartered?
MagicRNA is headquartered in Shenzhen, China.
Which VCs invest in companies like MagicRNA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at MagicRNA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MagicRNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.